Shanton Pharma Co., Ltd.   Report issue

For profit Phase 2
Founded: China (2016)

Organization Overview

First Clinical Trial
2018
NCT03857165
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Shanton Pharma Co., Ltd.